"
Team:ULB-Brussels/sponsors
From 2011.igem.org
(Difference between revisions)
| (4 intermediate revisions not shown) | |||
| Line 118: | Line 118: | ||
{ | { | ||
width:980px; | width:980px; | ||
| - | height: | + | height:860px; |
margin: auto; | margin: auto; | ||
padding-left: 5px; | padding-left: 5px; | ||
| Line 552: | Line 552: | ||
<a href="https://2011.igem.org/Team:ULB-Brussels">Home</a> | <a href="https://2011.igem.org/Team:ULB-Brussels">Home</a> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/project">Project</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/project">Project</a> | ||
| - | <a href="https://2011.igem.org/Team:ULB-Brussels/modeling">Modelling</a> | + | <a href="https://2011.igem.org/Team:ULB-Brussels/modeling">Modelling</a> |
| - | <a href="https://2011.igem.org/Team:ULB-Brussels/human">Human practice</a> | + | <a href="https://2011.igem.org/Team:ULB-Brussels/human">Human practice</a> |
| - | <a href="https://2011.igem.org/Team:ULB-Brussels/ | + | <a href="https://2011.igem.org/Team:ULB-Brussels/Discussion">Discussion</a> |
| - | <a href="https://2011.igem.org/Team:ULB-Brussels/parts">Parts</a> | + | <a href="https://2011.igem.org/Team:ULB-Brussels/parts">Parts</a> |
<a href="https://2011.igem.org/Team:ULB-Brussels/safety">Safety</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/safety">Safety</a> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/team">Team</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/team">Team</a> | ||
| - | <a id="couleur" | + | <a id="couleur" href="https://2011.igem.org/Team:ULB-Brussels/sponsors">Sponsors</a> |
| + | |||
</div> | </div> | ||
Latest revision as of 17:43, 21 September 2011
Sponsors
| UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2010. UCB is listed on Euronext Brussels. |
| Delphi Genetics was founded by Philipe Gabant in 2001 and their HQ is located in Gosselies in Belgium. Their main interest lies in research on more effective products and techniques for gene cloning and protein expression in bacteria, based on poison-antidote systems. |
| Our team is mostly composed of students from this faculty. They have been supporting us for now 3 years. |
| The Université Libre de Bruxelles, our university. |
| The Fonds Jean Brachet was founded in 1985 by professors, researchers and former students from the Molecular Biology Department of the ULB. Its main aim ? Collecting funds to help researchers in all possible ways. |
iGEM ULB Brussels Team - Contact us
